Akash W.

LYEONS is a neurotechnology company developing non-invasive, body-first solutions to support nervous system regulation and everyday neurohealth. Our technology uses gentle, heartbeat-like audio-tactile stimulation to provide the body with a physiological rhythm that may support calm, sleep, focus and resilience during moments of stress or overwhelm. Our first platform, the LYEONS Heart, is being developed through scientific research, human-centred design and ongoing collaboration with users, researchers and clinicians. Our work explores how sensory rhythms can influence physiological state, emotional regulation and cognitive performance. Our multidisciplinary team brings together expertise in neuroscience, engineering, clinical research, medical device development and lived experience. We are committed to translating promising neurotechnology into safe, accessible and meaningful solutions that people can use in everyday life. LYEONS is building a new generation of neurohealth technology at the intersection of neuroscience, physiology and human experience.

Finexus is a deep tier financing platform that helps democratize access to finance across the entire value chain. We enable companies to extend early payments to their deeper tier suppliers, in addition to their direct suppliers, while continuing to align their business practices with broader ESG goals Access to timely credit is a critical challenge for businesses, particularly for deep tier vendors. The lack of short-term credit availability can significantly hinder growth and sustainability, eventually impacting the buyer. Our approach seamlessly blends advanced technology with operational expertise to deliver unmatched value.

NeuroSpeechAI revolutionizes therapy for brain injury, stroke, and dementia patients through a suite of seven innovative apps. Incorporated in April 2023 as a UCL spinout by Professors Jenny Crinion and Alex Leff we merge advanced mobile game development with a groundbreaking, tailored speech recognition system. Our apps are designed to understand and support distorted vision and speech, enabling patients to use them independently for home-based therapy, while providing immediate, robust feedback on their progress. Our technology not only offers personalized therapeutic exercises but also employs algorithmic AI to continuously enhance the platform based on user performance data. This approach ensures that each patients experience is engaging, effective, and directly contributes to the improvement of their recovery. Available for both mobile and desktop, NeuroSpeechAIs mission is to make quality therapy accessible to everyone affected by acquired visual and language disorders. By offering our therapies on a global scale, we aim to speed up recovery and significantly improve the quality of life for our users, all from the comfort of their home. Dedicated to breaking down barriers in therapy access, NeuroSpeechAI is a testament to the power of combining medical research with digital innovation to create real-world solutions for those in need.

Aide is an award-winning digital health company. Our flagship product, Aide, helps patients and clinicians manage multiple chronic conditions. Our latest product, Mirror, helps patients remember everything from medical consultations. Our work has been consistently recognised for innovation in health. In 2025, we received an Innovate UK Biomedical Catalyst award to support patients living with haematological cancers. In 2024 Aide Health was selected to join the prestigious Google for Startups ‘AI for Health’ accelerator. In 2023, our research into novel use of conversational AI for hypertension patients was funded by the NIHR. We have a singular mission: to make prescribed care as effective as possible.

Asterix is the leading provider of remote GP resources. We support primary and urgent care providers to improve access to high-quality care for patients, at lower cost.

Thermology Health is a spin out from NPL - the UKs world-renowned National Metrology Institute. Thermology has developed a unique, patented technology for prevention of diabetic foot ulcers. Diabetic foot ulcers are one of the biggest complications of diabetes affecting over 20% of all diabetics worldwide.

AI-powered search designed for health professionals. Our mission is to empower every health professional to do their best work and provide better care for their patients.

Keyrails is a global payments ecosystem that enables individuals and businesses in any economy to have an equal shot at advancing their financial prosperity. Keyrails has created the simplest and most advanced solution for fintechs to unlock the global economy for their users. With Keyrails, fintechs can empower users to receive payments from any company, anywhere, in any currency and move them freely across the world.

Scan.com is transforming diagnostic imaging, a $500B+ global market, by rebuilding its outdated infrastructure from the ground up. Having built the UK’s largest marketplace for self-pay MRI scans, we’re now scaling at breakneck speed to become the world’s leading medical imaging platform. Our mission is clear: make medical imaging radically accessible—because early, efficient diagnostics save lives. Inefficiency shouldn’t cost lives. By integrating fragmented imaging providers, payers, and technology into a seamless, modern ecosystem, we’re creating an effortless, patient-first experience that improves healthcare outcomes globally. Backed by top-tier VCs across the US & Europe, we’ve raised $50M+ to date and are just getting started. Join us as we redefine the future of medical imaging.

Packaging Environmental Limited is a leading supplier of sustainable and eco-friendly food & drink packaging with a focus on products made from renewable materials. We pride ourselves in having supplied over 18K businesses from small delis and independent coffee shops to multi-national organisations across the UK and Europe. Formed in London in 2007, we had the vision to provide our customers with sustainable, high-quality and cost-effective packaging made from compostable and recycled and recyclable materials. Our ethos is to encourage our customers and end-users to move away from non-sustainable oil-based packaging options that were traditionally available at the time. In April 2023, we launched our very own Carbon Neutral packaging range. In 2020 we opened our European online stores into different territories in France, Germany, and Italy. We aim to continue our expansion by opening further online stores in Europe in the future, offering the best sustainable packaging alternatives at competitive prices to our European and UK customers alike. We love to work shoulder to shoulder with our customers, providing solutions to their packaging requirements and custom packaging design, no matter how large or small; we will gladly adapt to your needs with friendly and exceptional service. Please contact us on 020 3006 2432 or info@packagingenvironmental.co.uk for further information.

LYEONS is a neurotechnology company developing non-invasive, body-first solutions to support nervous system regulation and everyday neurohealth. Our technology uses gentle, heartbeat-like audio-tactile stimulation to provide the body with a physiological rhythm that may support calm, sleep, focus and resilience during moments of stress or overwhelm. Our first platform, the LYEONS Heart, is being developed through scientific research, human-centred design and ongoing collaboration with users, researchers and clinicians. Our work explores how sensory rhythms can influence physiological state, emotional regulation and cognitive performance. Our multidisciplinary team brings together expertise in neuroscience, engineering, clinical research, medical device development and lived experience. We are committed to translating promising neurotechnology into safe, accessible and meaningful solutions that people can use in everyday life. LYEONS is building a new generation of neurohealth technology at the intersection of neuroscience, physiology and human experience.

Finexus is a deep tier financing platform that helps democratize access to finance across the entire value chain. We enable companies to extend early payments to their deeper tier suppliers, in addition to their direct suppliers, while continuing to align their business practices with broader ESG goals Access to timely credit is a critical challenge for businesses, particularly for deep tier vendors. The lack of short-term credit availability can significantly hinder growth and sustainability, eventually impacting the buyer. Our approach seamlessly blends advanced technology with operational expertise to deliver unmatched value.

NeuroSpeechAI revolutionizes therapy for brain injury, stroke, and dementia patients through a suite of seven innovative apps. Incorporated in April 2023 as a UCL spinout by Professors Jenny Crinion and Alex Leff we merge advanced mobile game development with a groundbreaking, tailored speech recognition system. Our apps are designed to understand and support distorted vision and speech, enabling patients to use them independently for home-based therapy, while providing immediate, robust feedback on their progress. Our technology not only offers personalized therapeutic exercises but also employs algorithmic AI to continuously enhance the platform based on user performance data. This approach ensures that each patients experience is engaging, effective, and directly contributes to the improvement of their recovery. Available for both mobile and desktop, NeuroSpeechAIs mission is to make quality therapy accessible to everyone affected by acquired visual and language disorders. By offering our therapies on a global scale, we aim to speed up recovery and significantly improve the quality of life for our users, all from the comfort of their home. Dedicated to breaking down barriers in therapy access, NeuroSpeechAI is a testament to the power of combining medical research with digital innovation to create real-world solutions for those in need.

Aide is an award-winning digital health company. Our flagship product, Aide, helps patients and clinicians manage multiple chronic conditions. Our latest product, Mirror, helps patients remember everything from medical consultations. Our work has been consistently recognised for innovation in health. In 2025, we received an Innovate UK Biomedical Catalyst award to support patients living with haematological cancers. In 2024 Aide Health was selected to join the prestigious Google for Startups ‘AI for Health’ accelerator. In 2023, our research into novel use of conversational AI for hypertension patients was funded by the NIHR. We have a singular mission: to make prescribed care as effective as possible.

Cloudberries grow only at the extremes where Arctic tundra meets forest - rare, difficult to find, and commanding premium value. Like these resilient berries, we invest at the convergence points where physics meets its limits: where compute hits walls, materials need breakthroughs, and finance demands new infrastructure. We are Cloudberry Ventures because exceptional returns come from backing rare technologies and great founders that thrive where others see only barriers.